Clinical trial Recruiting at 1 site Interventional Ages 18 to 85

SupraSDRM vs standard dressing for full-thickness wounds requiring grafting

Official title: A Prospective Study Using SupraSDRM® in Promoting Healing and Reducing the Time to Grafting of Full-thickness Wounds

Run by The Metis Foundation · NCT06503406 · Data updated 2026-11-12

This study tests whether SupraSDRM® helps healing faster and makes skin grafting possible sooner in adults with full-thickness wounds compared to standard wound dressings.

Quick facts

Study typeInterventional
Ages18 Years to 85 Years
SexAll
Enrollment24 (estimated)
SponsorThe Metis Foundation
Academic / other
Locations1 site (Fort Sam Houston, Texas)
StatusRecruiting
StartedJanuary 8, 2026
Main results expectedDecember 2027
Study endsDecember 2027
Registry record updatedAugust 13, 2026
Trial IDNCT06503406 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 18–85 with a full-thickness traumatic, surgical, or excised burn wound not suitable for immediate grafting, and wound size between 5 and 125 cm2.

Probably not a fit

Patients with facial/genital wounds, active infection, uncontrolled diabetes, or other exclusion criteria may not experience benefit or could be at risk.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a prospective, randomized, controlled, multicenter study enrolling adults with full-thickness wounds not yet ready for grafting. Participants are assigned to SupraSDRM® or NovoSorb® BTM as the wound dressing. The trial assesses time to graft readiness and healing outcomes over a defined wound area (5–125 cm2). Twenty-four patients will be enrolled across participating centers, following standard inclusion and exclusion criteria. The study aims to determine whether SupraSDRM® can promote faster healing and reduce the time to grafting compared with current standard care.

Why it matters

Potential benefit: If successful, patients might experience quicker wound healing and shorter time to grafting, potentially improving recovery and reducing complications.

How similar studies have gone: Similar wound dressings have shown promise in promoting healing in other full-thickness wounds, but this exact comparative approach with SupraSDRM® is novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patient age ≥18 years and ≤85 years
* Full-thickness traumatic injury, surgical wound, or excised full-thickness burn (e.g., friction, contact, flame, scalding etiology), where immediate grafting is not deemed suitable by the treating surgeon
* Wound size ≥ 5cm2 not immediately suitable for graft application
* Subject or legally authorized representative is able and willing to sign informed consent

Exclusion Criteria:

* Study wound may not include areas of the face, and neck and genitalia.
* Wound with metal hardware exposure
* Pressure sores
* Wounds with residual malignancy
* Wound infection at the time of planned wound dressing application
* Wound that is a part of an active treatment arm of an interventional study (within 90 days of Screening Visit)
* Pregnancy/lactation
* Subjects who are unable to follow the protocol or who are likely to be non-compliant
* Subjects with uncontrolled diabetes (defined by Hgb A1C \>10)
* Subjects who are receiving systemic steroids or immune suppressive treatment
* Subject with a known allergy to polylactide, polycaprolactone, polyvinyl alcohol, trimethylene carbonate or resorbable suture materials.
* Prisoners

Where it's running

  • The United States Army Institute of Surgical Research
    Fort Sam Houston, Texas, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

  • Early detection of sepsis-related blood clotting problems in severe burn patients

    This study tests how well the JAAM-2 score can detect sepsis-induced coagulopathy early in adults with severe burns who develop sepsis in the ICU.

    Recruiting Center for Traumatology and Major Burns, Ben Arous · Tunis · NCT07914205

  • THERAVEX Tissue Care Spray Plus for Healing of Skin Wounds and Ulcers

    This observational review tests whether THERAVEX Tissue Care Spray Plus, used with standard wound care, helps heal various skin wounds and chronic ulcers in adults.

    Recruiting Biointelligent Technology Systems SL · Barcelona · NCT07617961

  • Geriatric Trauma Care Program for Older Adults Living Alone

    This study tests a digital support program to help older adults with limb injuries who live alone see if it improves their recovery and daily living after injury.

    Recruiting at 2 sites Kaohsiung Medical University Chung-Ho Memorial Hospital · Kaohsiung City, Kaohsiung and 1 other locations · NCT07610161

  • Efferon LPS hemoadsorption for severe burns

    This study tests whether adding Efferon LPS hemoadsorption to standard care can help burn patients with high illness scores see if their symptoms improve and prevent organ failure.

    Recruiting Efferon JSC · Moscow · NCT07568132

  • Wearable hip-robot training to improve walking after major lower-leg burns

    This 12-week program will try using a wearable hip-assist robot during daily physiotherapy to help adults who still have walking problems six months after large lower-extremity burns walk better.

    Recruiting Hangang Sacred Heart Hospital · Seoul · NCT07277166

  • Mortality in the ICU after trauma in Colombia

    This study tests what factors are linked to death among trauma patients admitted to the ICU and compares them with other ICU admissions in Colombian hospitals.

    Recruiting Hospital Departamental de Villavicencio · Villavicencio, Meta Department · NCT07208110

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.